abstract |
The present invention relates to aryldihydro-2H-benzo [b] [1,4] oxazinesulfonamides and related compounds, pharmaceutical compositions, methods of increasing RORĪ³ activity, methods of increasing the amount of IL-17 in a subject, and Methods of using such compounds to treat cancer and other medical disorders are provided. |